Deposit $100 to get a $100 trading bonus. Use the promo code AMANAWEB.
Deposit $200 to get a $100 trading bonus.
Use the promo code AMANAWEB.

-2.08%
Today
+0.74%
1D
Sun
Closed
Mon
10:01 AM ~ 6:30 PM
Tue
10:01 AM ~ 6:30 PM
Wed
10:01 AM ~ 6:30 PM
Thu
10:01 AM ~ 6:30 PM
Fri
10:01 AM ~ 6:30 PM
Sat
Closed
Name
Lakefront Biotherapeutics Leveraged ( NL )
Currency
EUR
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0144%
Overnight Fees Sell
-0.0023%
Market Cap
1.55B
Avg Daily Volume
81.42K
52 Week High
32.74 EUR
52 Week Low
22.92 EUR
Trading Hours
See hours
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01440% | $(0.144) |
| SELLS | -0.00230% | $(0.023) |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that is in phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Galapagos
+0.74%
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi
tradingview.com
0mo ago

Galapagos
+0.74%
Lakefront Receives Transparency Notification from Madison Avenue Partners
tradingview.com
1mo ago

Galapagos
+0.74%
Acquisition of Own Shares
tradingview.com
1mo ago

Show more
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.